After subsequent proteolytical unmasking of the CendR motif by the tumor-related urokinase plasminogen activator (uPA) and binding to NRP1, the peptides are micropinocytotically taken up and, subsequently, by a transcytosis cascade, distributed deep into the tumor parenchyma [242]. The gene discussed is NRP1; the disease is neoplasm.